MetLife Small Company Equity Fund Investor Shares (MSVVX)
| Fund Assets | 7.55M |
| Expense Ratio | 1.24% |
| Min. Investment | $5,000 |
| Turnover | 90.00% |
| Dividend (ttm) | 8.57 |
| Dividend Yield | 100.00% |
| Dividend Growth | 761.04% |
| Payout Frequency | Annual |
| Ex-Dividend Date | Dec 18, 2025 |
| Previous Close | 5.24 |
| YTD Return | 4.38% |
| 1-Year Return | 10.95% |
| 5-Year Return | 57.03% |
| 52-Week Low | 3.77 |
| 52-Week High | 5.39 |
| Beta (5Y) | n/a |
| Holdings | 84 |
| Inception Date | Dec 19, 2018 |
About MSVVX
MetLife Small Company Equity Fund Investor Shares is an actively managed mutual fund designed to provide long-term capital appreciation with lower volatility compared to the broader U.S. small company market. This fund primarily invests at least 80% of its net assets, plus borrowings, in equities of small-cap companies—typically businesses with smaller market capitalizations that are generally considered to have higher growth potential but also increased volatility relative to large-cap peers. The fund follows a "small blend" investment style, balancing exposure to both growth and value-oriented small-cap stocks across various sectors, including industrials, financial services, healthcare, and consumer cyclical industries. Its strategy aims to capture growth opportunities among smaller U.S. businesses while employing risk management processes intended to reduce overall portfolio fluctuations. The fund charges a net expense ratio of 1.23% for Investor Shares after waivers, and maintains a relatively high portfolio turnover rate, reflecting active trading as the managers adjust holdings. Overall, MetLife Small Company Equity Fund Investor Shares plays a role in diversifying portfolios with exposure to U.S. small-cap equities, offering investors potential for long-term growth with an emphasis on managing volatility.
Performance
MSVVX had a total return of 10.95% in the past year, including dividends. Since the fund's inception, the average annual return has been 36.75%.
Equivalent Funds
These are funds that follow the same index from the other major fund companies.
Other Share Classes
These are alternative share classes of the same fund, from the same provider.
| Symbol | Share Class | Expense Ratio |
|---|---|---|
| MSVIX | Institutional Shares | 0.99% |
Top 10 Holdings
18.51% of assets| Name | Symbol | Weight |
|---|---|---|
| Cash & Cash Equivalents | n/a | 3.10% |
| Axsome Therapeutics, Inc. | AXSM | 1.97% |
| State Street SPDR S&P Biotech ETF | XBI | 1.82% |
| Halozyme Therapeutics, Inc. | HALO | 1.76% |
| ADMA Biologics, Inc. | ADMA | 1.72% |
| Fortrea Holdings Inc. | FTRE | 1.69% |
| Alphatec Holdings, Inc. | ATEC | 1.66% |
| ACI Worldwide, Inc. | ACIW | 1.61% |
| Bruker Corporation | BRKR | 1.59% |
| ExlService Holdings, Inc. | EXLS | 1.59% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 18, 2025 | $8.5742 | Dec 19, 2025 |
| Dec 18, 2024 | $0.9958 | Dec 19, 2024 |
| Dec 28, 2023 | $0.0631 | Dec 29, 2023 |
| Dec 19, 2023 | $0.4663 | Dec 20, 2023 |
| Dec 29, 2022 | $0.0125 | Dec 30, 2022 |
| Dec 15, 2022 | $0.3052 | Dec 16, 2022 |